Does IPILIMUMAB Cause Hyperthyroidism? 525 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 525 reports of Hyperthyroidism have been filed in association with IPILIMUMAB (YERVOY). This represents 1.4% of all adverse event reports for IPILIMUMAB.
525
Reports of Hyperthyroidism with IPILIMUMAB
1.4%
of all IPILIMUMAB reports
44
Deaths
326
Hospitalizations
How Dangerous Is Hyperthyroidism From IPILIMUMAB?
Of the 525 reports, 44 (8.4%) resulted in death, 326 (62.1%) required hospitalization, and 50 (9.5%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
Yes, Hyperthyroidism is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
PREDNISONE (220)
Which IPILIMUMAB Alternatives Have Lower Hyperthyroidism Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN